Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by brad129on Feb 02, 2022 3:13pm
127 Views
Post# 34390327

RE:RE:RE:RE:RE:RE:RE:UPDATE NEEDED

RE:RE:RE:RE:RE:RE:RE:UPDATE NEEDED

What's more important to our core business, really material info, Barbados has accepted our Covid test, or Aristotle is hitting the market by storm and we are relentlessly trying to staff and keep up with demand? Anyone in the field (competition) knows we have this test and are trying to come up with their own. This is all public info. You know what a statement like that would do to our share price?



Mykndrsn wrote: Transparency isn't necessarily good business. Sales figures are generally not public information until necessary. Good practice and common sense. Whatever the results it will never please everyone. (or anyone on this board). 

 

<< Previous
Bullboard Posts
Next >>